ArticleThe Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology2016

Daclatasvir plus sofosbuvir regimen sheds promising light on future hepatitis C virus genotype 3 therapies.

Ali Murat Kahveci et al.PubMed ↗Publisher ↗

No numbers read from the abstract.